tailieunhanh - Validation of an NGS mutation detection panel for melanoma

Knowledge of the genotype of melanoma is important to guide patient management. Identification of mutations in BRAF and c-KIT lead directly to targeted treatment, but it is also helpful to know if there are driver oncogene mutations in NRAS, GNAQ or GNA11 as these patients may benefit from alternative strategies such as immunotherapy. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN